Cigna Group stock had its Relative Strength (RS) Rating upgraded from 79 to 86 Friday.
IBD's unique RS Rating tracks market leadership by using a 1 (worst) to 99 (best) score that identifies how a stock's price action over the trailing 52 weeks matches up against other publicly traded companies.
Decades of market research shows that the stocks that go on to make the biggest gains tend to have an RS Rating north of 80 in the early stages of their moves.
Looking For The Best Stocks To Buy And Watch? Start Here
Is Cigna Group Stock A Buy?
Cigna Group stock is working on a cup without handle with a 370.82 entry. See if healthcare stock can clear the breakout price in heavy volume. This is not the time to buy stocks during a market correction, but build a watchlist of possible emerging leaders once the market trend turns around.
The healthcare firm posted -2% EPS growth in its most recent report. Sales rose 28%. Look for the next report on or around May 2.
Cigna Group stock earns the No. 2 rank among its peers in the Medical-Managed Care industry group. Molina Healthcare is the top-ranked stock within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
